{"id":"https://openalex.org/W2906554396","doi":"https://doi.org/10.3389/fimmu.2018.03017","title":"A Computational Approach Identifies Immunogenic Features of Prognosis in Human Cancers","display_name":"A Computational Approach Identifies Immunogenic Features of Prognosis in Human Cancers","publication_year":2018,"publication_date":"2018-12-21","ids":{"openalex":"https://openalex.org/W2906554396","doi":"https://doi.org/10.3389/fimmu.2018.03017","mag":"2906554396","pmid":"https://pubmed.ncbi.nlm.nih.gov/30622534","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6308325"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2018.03017","doi":"https://doi.org/10.3389/fimmu.2018.03017","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2018.03017","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2018.03017/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2018.03017/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019518784","display_name":"Malini Manoharan","orcid":"https://orcid.org/0000-0001-7177-516X","observed_orcids":["https://orcid.org/0000-0001-7177-516X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Malini Manoharan","raw_affiliation_strings":["MedGenome Labs Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MedGenome Labs Ltd., Bangalore, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048280548","display_name":"Nitin Mandloi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nitin Mandloi","raw_affiliation_strings":["MedGenome Labs Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MedGenome Labs Ltd., Bangalore, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047729035","display_name":"Sushri Priyadarshini","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sushri Priyadarshini","raw_affiliation_strings":["MedGenome Labs Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MedGenome Labs Ltd., Bangalore, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005993955","display_name":"Ashwini Patil","orcid":"https://orcid.org/0000-0002-3353-1970","observed_orcids":["https://orcid.org/0000-0002-3353-1970"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ashwini Patil","raw_affiliation_strings":["MedGenome Inc., Foster City, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MedGenome Inc., Foster City, CA, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101517032","display_name":"Rohit K. Gupta","orcid":"https://orcid.org/0000-0002-6897-7083","observed_orcids":["https://orcid.org/0000-0002-6897-7083"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rohit Gupta","raw_affiliation_strings":["MedGenome Labs Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MedGenome Labs Ltd., Bangalore, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083298753","display_name":"Laxman Iyer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laxman Iyer","raw_affiliation_strings":["MedGenome Labs Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MedGenome Labs Ltd., Bangalore, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091353375","display_name":"Ravi Kr Gupta","orcid":"https://orcid.org/0000-0001-6086-2612","observed_orcids":["https://orcid.org/0000-0001-6086-2612"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Ravi Gupta","raw_affiliation_strings":["MedGenome Labs Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MedGenome Labs Ltd., Bangalore, India","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047179282","display_name":"Amitabha Chaudhuri","orcid":"https://orcid.org/0000-0002-1493-9874","observed_orcids":["https://orcid.org/0000-0002-1493-9874"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Amitabha Chaudhuri","raw_affiliation_strings":["MedGenome Inc., Foster City, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MedGenome Inc., Foster City, CA, United States","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5047179282","https://openalex.org/A5091353375"],"corresponding_institution_ids":[],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.3169,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":{"value":0.62290843,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"9","issue":null,"first_page":"3017","last_page":"3017"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10885","display_name":"Gene expression and cancer classification","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.824999988079071},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.8100000023841858},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.6200000047683716},{"id":"https://openalex.org/keywords/t-cell-exhaustion","display_name":"T cell exhaustion","score":0.6899999976158142},{"id":"https://openalex.org/keywords/ctla-4","display_name":"CTLA-4","score":0.8899999856948853},{"id":"https://openalex.org/keywords/tim-3","display_name":"TIM-3","score":0.9409999847412109},{"id":"https://openalex.org/keywords/lag-3","display_name":"LAG-3","score":0.996999979019165},{"id":"https://openalex.org/keywords/pi3k-signaling","display_name":"PI3K signaling","score":0.8740000128746033},{"id":"https://openalex.org/keywords/t-cell-receptor-signaling","display_name":"T cell receptor signaling","score":0.7020000219345093},{"id":"https://openalex.org/keywords/gene-expression-signatures","display_name":"gene expression signatures","score":0.6460000276565552},{"id":"https://openalex.org/keywords/cancer-prognosis","display_name":"cancer prognosis","score":0.5950000286102295},{"id":"https://openalex.org/keywords/long-term-survival","display_name":"long-term survival","score":0.7749999761581421},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8510000109672546},{"id":"https://openalex.org/keywords/tumor-infiltrating-immune-cells","display_name":"tumor-infiltrating immune cells","score":0.7730000019073486}],"concepts":[{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.6278950572013855},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6109042167663574},{"id":"https://openalex.org/C73588182","wikidata":"https://www.wikidata.org/wiki/Q2663023","display_name":"Cytolysis","level":4,"score":0.5286260843276978},{"id":"https://openalex.org/C19317047","wikidata":"https://www.wikidata.org/wiki/Q412037","display_name":"T-cell receptor","level":4,"score":0.5261280536651611},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.48399922251701355},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.464013934135437},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.45313164591789246},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4097839593887329},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.40577778220176697},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.3925439715385437},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.343927264213562},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07383319735527039},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000072597","descriptor_name":"Hepatitis A Virus Cellular Receptor 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000077982","descriptor_name":"Progression-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000093322","descriptor_name":"Lymphocyte Activation Gene 3 Protein","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015703","descriptor_name":"Antigens, CD","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015703","descriptor_name":"Antigens, CD","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D016246","descriptor_name":"Lymphocytes, Tumor-Infiltrating","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D018414","descriptor_name":"CD8-Positive T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D018579","descriptor_name":"Patient Selection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019295","descriptor_name":"Computational Biology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020869","descriptor_name":"Gene Expression Profiling","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D053208","descriptor_name":"Kaplan-Meier Estimate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D060908","descriptor_name":"CTLA-4 Antigen","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D060908","descriptor_name":"CTLA-4 Antigen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D066264","descriptor_name":"Datasets as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.3389/fimmu.2018.03017","doi":"https://doi.org/10.3389/fimmu.2018.03017","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2018.03017","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2018.03017/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5296589","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6308325","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6308325","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6308325","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:30622534","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30622534","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Evaluation Study"},{"id":"pmh:oai:doaj.org/article:1f50028f778442c782b8f4d374561023","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/1f50028f778442c782b8f4d374561023","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 9 (2018)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2018.03017","doi":"https://doi.org/10.3389/fimmu.2018.03017","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2018.03017","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2018.03017/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.979200005531311,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2906554396.pdf","grobid_xml":"https://content.openalex.org/works/W2906554396.grobid-xml"},"referenced_works_count":67,"referenced_works":["https://openalex.org/W95900856","https://openalex.org/W1019458012","https://openalex.org/W1498931318","https://openalex.org/W1966107523","https://openalex.org/W1981978810","https://openalex.org/W1986246471","https://openalex.org/W1986935067","https://openalex.org/W1989277387","https://openalex.org/W2009719437","https://openalex.org/W2015474424","https://openalex.org/W2025738474","https://openalex.org/W2028433016","https://openalex.org/W2033278321","https://openalex.org/W2049553585","https://openalex.org/W2050139225","https://openalex.org/W2050558251","https://openalex.org/W2053725511","https://openalex.org/W2056370171","https://openalex.org/W2060469376","https://openalex.org/W2068409497","https://openalex.org/W2090789702","https://openalex.org/W2093773243","https://openalex.org/W2095864883","https://openalex.org/W2102144390","https://openalex.org/W2104584195","https://openalex.org/W2109485845","https://openalex.org/W2122385884","https://openalex.org/W2130410032","https://openalex.org/W2130430382","https://openalex.org/W2166178545","https://openalex.org/W2168631000","https://openalex.org/W2216871881","https://openalex.org/W2235798950","https://openalex.org/W2272159258","https://openalex.org/W2302088846","https://openalex.org/W2332292689","https://openalex.org/W2332521027","https://openalex.org/W2340129316","https://openalex.org/W2371138393","https://openalex.org/W2435243879","https://openalex.org/W2461410982","https://openalex.org/W2470477092","https://openalex.org/W2503987610","https://openalex.org/W2507880739","https://openalex.org/W2533508881","https://openalex.org/W2553481980","https://openalex.org/W2560367415","https://openalex.org/W2566599522","https://openalex.org/W2578528809","https://openalex.org/W2582414407","https://openalex.org/W2596678748","https://openalex.org/W2603523955","https://openalex.org/W2613370968","https://openalex.org/W2624831627","https://openalex.org/W2747882868","https://openalex.org/W2753432434","https://openalex.org/W2761575992","https://openalex.org/W2788357641","https://openalex.org/W2792656817","https://openalex.org/W2804569878","https://openalex.org/W2949273159","https://openalex.org/W2950911467","https://openalex.org/W2952001873","https://openalex.org/W4233698560","https://openalex.org/W4237107236","https://openalex.org/W4246664779","https://openalex.org/W6674370923"],"related_works":["https://openalex.org/W7164905295","https://openalex.org/W4283583355","https://openalex.org/W2282819656","https://openalex.org/W2514028337","https://openalex.org/W2921820448","https://openalex.org/W3105826467","https://openalex.org/W7100591168","https://openalex.org/W3046960707","https://openalex.org/W4391678286","https://openalex.org/W2986360475"],"abstract_inverted_index":{"A":[0],"large":[1],"number":[2],"of":[3,53,89,103],"tumor":[4,115],"intrinsic":[5],"and":[6,32,62,80,93,106],"extrinsic":[7],"factors":[8],"determine":[9],"long-term":[10,38],"survival":[11,71],"in":[12],"human":[13],"cancers.":[14],"In":[15],"this":[16],"study,":[17],"we":[18],"stratified":[19],"9120":[20],"tumors":[21,44,76],"from":[22,128],"33":[23],"cancers":[24],"with":[25,37,58],"respect":[26],"to":[27,96,112],"their":[28],"immune":[29],"cell":[30,65],"content":[31],"identified":[33],"immunogenomic":[34],"features":[35],"associated":[36],"survival.":[39],"Our":[40],"analysis":[41],"demonstrates":[42],"that":[43],"infiltrated":[45,77],"by":[46,78,86],"CD8+":[47,82],"T":[48,64,83],"cells":[49,84],"expressing":[50],"higher":[51],"levels":[52],"activation":[54],"marker":[55],"(PD1hi)":[56],"along":[57],"TCR":[59],"signaling":[60,98],"genes":[61,94],"cytolytic":[63],"markers":[66],"(IL2hi/TNF-\u03b1hi/IFN-\u03b3hi/GZMA-Bhi)":[67],"extend":[68],"survival,":[69],"whereas":[70],"benefit":[72,127],"was":[73],"absent":[74],"for":[75],"anergic":[79],"hyperexhausted":[81],"characterized":[85],"high":[87],"expression":[88,110],"CTLA-4,":[90],"TIM3,":[91],"LAG3":[92],"linked":[95],"PI3K":[97],"pathway.":[99],"The":[100],"computational":[101],"approach":[102],"using":[104],"robust":[105],"highly":[107],"specific":[108],"gene":[109],"signatures":[111],"deconvolute":[113],"the":[114],"microenvironment":[116],"has":[117],"important":[118],"clinical":[119],"applications,":[120],"such":[121],"as":[122],"selecting":[123],"patients":[124],"who":[125],"will":[126],"checkpoint":[129],"inhibitor":[130],"treatment.":[131]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-01-01T00:00:00"}